This review aims to this review aims to systematically evaluate the molecular mechanisms underlying aberrant activation of key angiogenic signaling pathways (NOTCH, Wnt/β-catenin, Ang/Tie, FGF, HGF, VEGF, and PI3K/AKT) in HCC progression and therapeutic resistance. This evidence concerns the gene VEGFA and hepatocellular carcinoma.